N. N. Aksenov
N. N. Aksenov has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anna V. Aksenova
Chazov National Medical Research Center of Cardiology
2 shared publications - Elena V. Gorbunova
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases
2 shared publications - Elena V. Oshchepkova
Chazov National Medical Research Center of Cardiology
2 shared publications - Irina Evgenievna Chazova
E.I. Chazov National Medical Research Center Of Cardiology
2 shared publications - Sergey A. Makarov
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”; State Budgetary Healthcare Institution “Kuzbass Clinical Cardiology Dispensary named after Academician L.S. Barbarash
2 shared publications N. Z. Musaeva
E.I. Chazov National Medical Research Center Of Cardiology
1 shared publication
Latest Publications
- Open Access
- 25 June 2024
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 21 (2) , 19-26
Controlled and uncontrolled arterial hypertension: comparison of clinical and demographic characteristics in patients (according to the National Registry of Hypertension, 2019-2022)
Aim: to analyze the features of antihypertensive therapy in a sample of patients with arterial hypertension observed in primary healthcare (2019-2022), to identify the features of therapy in patients with uncontrolled and controlled hypertension. Materials and methods. An analysis was made of antihypertensive therapy in 4543 patients, the frequency of prescription of various combinations ofantihypertensive drugs. For statistical data processing, the SPSS statistical software package was used. Drug combinations prescribed in less than 2% of cases were excluded from the graphical presentation. Results. The majority of patients with hypertension were prescribed combined AHT (2, 3 and 4-component therapy represented in 28.3 %, 33 %, 24.8 %, respectively). More than 90 % of patients receive drugs that block the RAAS system, more than 85 % – BB. Every third patient received a CCB, diuretic therapy most often prescribed mineralocorticoid receptor antagonists (39.8 %), loop diuretics (20 %). Thiazide-like diuretics are prescribed 1.8 times more often than thiazide ones (18.6 % and 10.1 %). In the structure of monotherapy in patients with hypertension, the leading prescriptions are BBs, ACEIs and ARBs (43.3 %; 31.4 %; 15.1 %) with a high incidence of coronary heart disease and heart failure. Combinations of BB, ACEI and ARB form the most frequently prescribed double combinations (BB+ACEI – 48.3 %; ARB and BB – 22.8 %). Almost all of the most commonly prescribed 4-antihypertensive combinations contained MRA. Among patients with controlled and uncontrolled hypertension, the frequency of prescription of different classes of antihypertensive drugs as monotherapy did not differ. Features of combination therapy in patients with uncontrolled hypertension included more frequent prescription of BB+ARB (25.6 % vs. 20.8 %), BB+ARB+TlD (15.7 % vs. 10.3 %), BB+ARB+CCB (11.1% vs. 6.3 %), ARB+CCBd+TlD (2.9 % vs. 1 %), BB+BRA+CCBd+TlD (15.3 % vs. 8.1 %), BB+ ACEI+CCBd+TlD (7.1 % vs. 2 %), BB+ACEI+CCBd+TlD+AB (5.3 % vs. 0 %), BB+ARB+CCBd+TlD+AB (5.3 % vs. 0 %). Patients with controlled hypertension were more often prescribed BB+ACEI (53.5 % vs. 41.3 %), BB+ACEI+MRA (22.8 % vs. 13.5 %), BB+ACEI+LD (3.6 % vs. 1.4 %), BB+ACEI+LD+MRA (27.1 % vs. 14.1 %), BB+ACEI+CCBd+MRA (19.6 % vs. 5.8 %), BB+ACEI+TD+MRA+LD (2.5 times, (23.8 % vs. 9.6 %)), BB+ACEI+CCBd+MRA+TD (5 times, (14.9 % vs. 2.9 %). Сonclusions. Further escalation of the use of combination therapy is necessary given the high rate of failure to achieve target values.
- 25 June 2024
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 21 (2) , 19-26
Open AccessControlled and uncontrolled arterial hypertension: comparison of clinical and demographic characteristics in patients (according to the National Registry of Hypertension, 2019-2022)
Aim: to analyze the features of antihypertensive therapy in a sample of patients with arterial hypertension observed in primary healthcare (2019-2022), to identify the features of therapy in patients with uncontrolled and controlled hypertension. Materials and methods. An analysis was made of antihypertensive therapy in 4543 patients, the frequency of prescription of various combinations ofantihypertensive drugs. For statistical data processing, the SPSS statistical software package was used. Drug combinations prescribed in less than 2% of cases were excluded from the graphical presentation. Results. The majority of patients with hypertension were prescribed combined AHT (2, 3 and 4-component therapy represented in 28.3 %, 33 %, 24.8 %, respectively). More than 90 % of patients receive drugs that block the RAAS system, more than 85 % – BB. Every third patient received a CCB, diuretic therapy most often prescribed mineralocorticoid receptor antagonists (39.8 %), loop diuretics (20 %). Thiazide-like diuretics are prescribed 1.8 times more often than thiazide ones (18.6 % and 10.1 %). In the structure of monotherapy in patients with hypertension, the leading prescriptions are BBs, ACEIs and ARBs (43.3 %; 31.4 %; 15.1 %) with a high incidence of coronary heart disease and heart failure. Combinations of BB, ACEI and ARB form the most frequently prescribed double combinations (BB+ACEI – 48.3 %; ARB and BB – 22.8 %). Almost all of the most commonly prescribed 4-antihypertensive combinations contained MRA. Among patients with controlled and uncontrolled hypertension, the frequency of prescription of different classes of antihypertensive drugs as monotherapy did not differ. Features of combination therapy in patients with uncontrolled hypertension included more frequent prescription of BB+ARB (25.6 % vs. 20.8 %), BB+ARB+TlD (15.7 % vs. 10.3 %), BB+ARB+CCB (11.1% vs. 6.3 %), ARB+CCBd+TlD (2.9 % vs. 1 %), BB+BRA+CCBd+TlD (15.3 % vs. 8.1 %), BB+ ACEI+CCBd+TlD (7.1 % vs. 2 %), BB+ACEI+CCBd+TlD+AB (5.3 % vs. 0 %), BB+ARB+CCBd+TlD+AB (5.3 % vs. 0 %). Patients with controlled hypertension were more often prescribed BB+ACEI (53.5 % vs. 41.3 %), BB+ACEI+MRA (22.8 % vs. 13.5 %), BB+ACEI+LD (3.6 % vs. 1.4 %), BB+ACEI+LD+MRA (27.1 % vs. 14.1 %), BB+ACEI+CCBd+MRA (19.6 % vs. 5.8 %), BB+ACEI+TD+MRA+LD (2.5 times, (23.8 % vs. 9.6 %)), BB+ACEI+CCBd+MRA+TD (5 times, (14.9 % vs. 2.9 %). Сonclusions. Further escalation of the use of combination therapy is necessary given the high rate of failure to achieve target values.
- Open Access
- 25 March 2024
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 21 (1) , 15-20
Controlled and uncontrolled arterial hypertension: comparison of clinical and demographic characteristics in patients (according to the National Registry of Hypertension, 2019-2022)
Aim: to study the clinical and demographic characteristics of patients in a sample of patients with arterial hypertension observed in primary healthcare (20192022). To compare data from patients with uncontrolled and controlled hypertension.Materials and methods. An analysis of medical data of 4543 patients was carried out (history, clinical and laboratory data, concomitant cardiovascular diseases, type 2 diabetes mellitus, chronic kidney disease, revascularization (coronary bypass grafting, transluminal balloon angioplasty of the coronary arteries). For statistical data processing, the SPSS statistical software package was used.Results. The patients in the study sample were middle-aged and elderly. 51,5% of patients did not achieve target blood pressure values. More than 90% of patients in the studied sample are high and very high risk patients. The ratio of groups of patients with controlled and uncontrolled arterial hypertension among patients of different ages did not differ. Higher values of low-density lipoprotein cholesterol, a higher frequency (1,3 times) of failure to achieve target values of low-density lipoprotein cholesterol Сonclusions. In hypertensive patients, more careful monitoring of cardiovascular risk factors is required, including blood pressure levels and achieving target LDL cholesterol levels. The association of a higher incidence of obesity, type 2 diabetes mellitus and the severity of dyslipidemia with uncontrolled hypertension may indicate less adherence of patients to both drug and non-drug treatment methods. While the presence of coronary heart disease, surgical interventions performed on the coronary arteries can serve as an illustration of increased adherence to therapy when hypertension is combined with coronary heart disease.
- 25 March 2024
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 21 (1) , 15-20
Open AccessControlled and uncontrolled arterial hypertension: comparison of clinical and demographic characteristics in patients (according to the National Registry of Hypertension, 2019-2022)
Aim: to study the clinical and demographic characteristics of patients in a sample of patients with arterial hypertension observed in primary healthcare (20192022). To compare data from patients with uncontrolled and controlled hypertension.Materials and methods. An analysis of medical data of 4543 patients was carried out (history, clinical and laboratory data, concomitant cardiovascular diseases, type 2 diabetes mellitus, chronic kidney disease, revascularization (coronary bypass grafting, transluminal balloon angioplasty of the coronary arteries). For statistical data processing, the SPSS statistical software package was used.Results. The patients in the study sample were middle-aged and elderly. 51,5% of patients did not achieve target blood pressure values. More than 90% of patients in the studied sample are high and very high risk patients. The ratio of groups of patients with controlled and uncontrolled arterial hypertension among patients of different ages did not differ. Higher values of low-density lipoprotein cholesterol, a higher frequency (1,3 times) of failure to achieve target values of low-density lipoprotein cholesterol Сonclusions. In hypertensive patients, more careful monitoring of cardiovascular risk factors is required, including blood pressure levels and achieving target LDL cholesterol levels. The association of a higher incidence of obesity, type 2 diabetes mellitus and the severity of dyslipidemia with uncontrolled hypertension may indicate less adherence of patients to both drug and non-drug treatment methods. While the presence of coronary heart disease, surgical interventions performed on the coronary arteries can serve as an illustration of increased adherence to therapy when hypertension is combined with coronary heart disease.